Shares of Clarivate PLC (NYSE:CLVT – Get Free Report) have received an average rating of “Reduce” from the eight ratings firms that are covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a sell recommendation and five have given a hold recommendation to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $3.2167.
CLVT has been the topic of several research analyst reports. Barclays decreased their target price on Clarivate from $4.00 to $2.40 and set an “underweight” rating on the stock in a report on Wednesday, February 25th. Royal Bank Of Canada reduced their price target on shares of Clarivate from $5.00 to $3.00 and set a “sector perform” rating on the stock in a research report on Wednesday, February 25th. Weiss Ratings restated a “sell (e+)” rating on shares of Clarivate in a research report on Friday, March 27th. Wall Street Zen raised shares of Clarivate from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Finally, Citigroup reduced their target price on shares of Clarivate from $4.25 to $2.80 and set a “neutral” rating on the stock in a research report on Wednesday, March 4th.
Read Our Latest Research Report on CLVT
Institutional Inflows and Outflows
Clarivate Stock Performance
NYSE CLVT opened at $2.40 on Wednesday. The firm has a market cap of $1.53 billion, a price-to-earnings ratio of -11.40 and a beta of 1.36. The company has a 50 day moving average of $2.53 and a 200-day moving average of $2.76. The company has a current ratio of 0.84, a quick ratio of 0.84 and a debt-to-equity ratio of 0.89. Clarivate has a 1-year low of $1.66 and a 1-year high of $4.77.
Clarivate (NYSE:CLVT – Get Free Report) last announced its earnings results on Wednesday, April 29th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.14 by $0.04. Clarivate had a positive return on equity of 8.82% and a negative net margin of 5.61%.The business had revenue of $585.50 million for the quarter, compared to the consensus estimate of $569.50 million. During the same period in the previous year, the business earned $0.14 EPS. Clarivate’s revenue was down 1.4% compared to the same quarter last year. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. On average, equities analysts forecast that Clarivate will post 0.65 earnings per share for the current fiscal year.
About Clarivate
Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.
Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.
Recommended Stories
- Five stocks we like better than Clarivate
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.
